Protolabs Supports MIT Industrial Performance Center Research Fellows to Accelerate U.S. Medical and Aerospace Manufacturing Innovation

MINNEAPOLIS–(BUSINESS WIRE)–Protolabs (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced a grant to support research fellows at the MIT Industrial Performance Center as they study leading U.S. manufacturing innovators and identify what it takes to scale the nation’s most advanced technologies.

Protolabs horizontal rgb black
Protolabs horizontal rgb black

The U.S. leads the world in developing breakthrough technologies from new aircrafts to medical technologies, but manufacturers still face significant challenges when bringing those innovations to large-scale production. The research will examine the strategies, capabilities and conditions that can help U.S. manufacturers turn American innovation into domestic production at scale, strengthening the U.S. economy and national security.

“We feel that there is significant momentum to transform American manufacturing through innovation and entrepreneurship,” said Ben Armstrong, executive director of the MIT Industrial Performance Center.

“We want to thank Protolabs for their support to study how American aerospace and medical companies innovate and scale up faster. For decades, inventors who started to build their companies in the U.S. moved production abroad as they grew. We are seeing growing demand for companies to scale up new technologies in the U.S., but there is not yet an obvious path for doing so. With this support from Protolabs, we’re focusing on today’s manufacturing pioneers that are finding ways to scale in the U.S. and we’re hoping to identify operating models, financial strategies, and public policies that can strengthen America’s industrial base for the long-term.”

The grant will enable the Industrial Performance Center to develop a manufacturing innovation index and advance the Initiative for New Manufacturing’s research program on high-growth manufacturing companies.

“Protolabs is at the center of American innovation, especially in critical industries like aerospace and medical devices,” said Suresh Krishna, President and CEO of Protolabs. “Protolabs pioneered rapid product development through the use of technology-enabled software, and needs to focus now, more than ever, on developing and deploying physical AI to scale up the American manufacturing and supply chain ecosystem.”

The manufacturing innovation index is a first-of-its-kind research endeavor to measure the changing market for manufactured products, tracking new and emerging manufacturing companies, the products they are developing and the technologies and techniques they use to make them.

The Initiative for New Manufacturing’s research program will identify how American factories can transform their operations to boost productivity, drive innovation and adapt to changing employment landscape in manufacturing. Support from Protolabs will enable the Initiative’s research fellows to study factories at the frontier of the aerospace, defense and medical device industries and identify practices that can help strengthen American manufacturing more broadly.

About Protolabs

Protolabs (NYSE: PRLB) is the world’s fastest manufacturing service enabling companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey. Get started now at protolabs.com.

Contacts

Investor Relations Contacts:
Protolabs

Ryan Johnsrud, 612-225-4873

Senior Manager, IR and Corporate Development

[email protected]

Gateway Group, Inc.

949-574-3860

[email protected]

Media Contact:
Protolabs

Brent Renneke, 763-479-7704

Corporate Communications Manager

[email protected]

Allie Potter

Skyya PR for Protolabs

[email protected]
218-766-8856

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.